Format

Send to

Choose Destination
Cytokine. 2016 Aug;84:63-73. doi: 10.1016/j.cyto.2016.05.015. Epub 2016 May 30.

New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.

Author information

1
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States. Electronic address: Joshua.J.Obar@dartmouth.edu.
2
Infectious Disease Service, Department of Medicine, Sloan Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; Immunology Program, Sloan Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, United States. Electronic address: hohlt@mskcc.org.
3
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States. Electronic address: Robert.a.cramer.jr@dartmouth.edu.

Abstract

Invasive aspergillosis (IA) remains a devastating disease in immune compromised patients despite significant advances in our understanding of fungal virulence and host defense mechanisms. In this review, we summarize important research advances in the fight against IA with particular focus on early events in the interactions between Aspergillus fumigatus and the host that occur in the respiratory tract. Advances in understanding mechanisms of immune effector cell recruitment, antifungal effector mechanisms, and how the dynamic host-fungal interaction alters the local microenvironment to effect outcomes are highlighted. These advances illustrate exciting new therapeutic opportunities, but also emphasize the importance of understanding each unique fungus-host interaction for improving patient outcomes.

KEYWORDS:

Antifungal effector; Aspergillus fumigatus; Fungal virulence; Invasive aspergillosis; Phagocytes

PMID:
27253487
PMCID:
PMC4904826
DOI:
10.1016/j.cyto.2016.05.015
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center